Effect of azilsartan on myocardial remodeling after acute myocardial infarction.

Wang, Jing; Ding, Ying; Yao, Yi-Ren; Liu, Hong-Yang; Gu, Yang

Wang, Jing; Ding, Ying; Yao, Yi-Ren; Liu, Hong-Yang; Gu, Yang.

Afiliação

Wang J; Department of Cardiology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, 223300, China.
Ding Y; Department of Cardiology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, 223300, China.
Yao YR; Department of Cardiology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, 223300, China.
Liu HY; Department of Cardiology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, 223300, China.
Gu Y; Department of Cardiology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, 223300, China. guyang1028@163.com.

Eur J Clin Pharmacol ; 80(2): 223-230, 2024 Feb.

Article em En | MEDLINE | ID: mdl-37991525

Assuntos

Benzimidazóis; Infarto do Miocárdio; Oxidiazóis; Intervenção Coronária Percutânea; Humanos; Volume Sistólico; Função Ventricular Esquerda; Infarto do Miocárdio/tratamento farmacológico

Palavras-chave

Azilsartan; C1q tumor necrosis factor-associated protein 1; Myocardial remodeling after acute myocardial infarction

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxidiazóis / Benzimidazóis / Intervenção Coronária Percutânea / Infarto do Miocárdio Limite: Humans Idioma: En Revista: Eur J Clin Pharmacol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google